EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive analysis of the cerebrospinal fluid and serum metabolome in neurological diseases

Carolin Otto, Rea Kalantzis, Dorothee Kübler-Weller, Andrea A Kühn, Tina Böld, Armin Regler, Selina Strathmeyer, Johannes Wittmann, Klemens Ruprecht, Steffen Heelemann

Journal of Neuroinflammation · 26.09.2024 · 21 (1)

DOI: 10.1186/s12974-024-03218-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroinflammation, online erschienen am 26.09.2024. Verfasst von Carolin Otto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Chari…. Hauptthemen laut MEDLINE: Metabolome, Nervous System Diseases, Magnetic Resonance Spectroscopy. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Charité - Universitätsmedizin Berlin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Comprehensive characterization of the metabolome in cerebrospinal fluid (CSF) and serum by Nuclear Magnetic Resonance (NMR) spectroscopy may identify biomarkers and contribute to the understanding of the pathophysiology of neurological diseases.

Methods

Metabolites were determined by NMR spectroscopy in stored CSF/serum samples of 20 patients with Parkinson’s disease, 25 patients with other neuro-degenerative diseases, 22 patients with cerebral ischemia, 48 patients with multiple sclerosis, and 58 control patients with normal CSF findings. The data set was analysed using descriptive and multivariate statistics, as well as machine learning models.

Results

CSF glucose and lactic acid measured by NMR spectroscopy and routine clinical chemistry showed a strong correlation between both methods (glucose, R 2 = 0.87, n = 173; lactic acid, R 2 = 0.74, n = 173). NMR spectroscopy detected a total of 99 metabolites; 51 in both, CSF and serum, 16 in CSF only, and 32 in serum only. CSF concentrations of some metabolites increased with age and/or decreasing blood–brain-barrier function. Metabolite detection rates were overall similar among the different disease groups. However, in two-group comparisons, absolute metabolite levels in CSF and serum discriminated between multiple sclerosis and neurodegenerative diseases (area under the curve (AUC) = 0.96), multiple sclerosis and Parkinson’s disease (AUC = 0.89), and Parkinson’s disease and control patients (AUC = 0.91), as demonstrated by random forest statistical models. Orthogonal partial least square discriminant analysis using absolute metabolite levels in CSF and serum furthermore permitted separation of Parkinson’s disease and neurodegenerative diseases. CSF propionic acid levels were about fourfold lower in Parkinson’s disease as compared to neurodegenerative diseases.

Conclusions

These findings outline the landscape of the CSF and serum metabolome in different categories of neurological diseases and identify age and blood–brain-barrier function as relevant co-factors for CSF levels of certain metabolites. Metabolome profiles as determined by NMR spectroscopy may potentially aid in differentiating groups of patients with different neurological diseases, including clinically meaningful differentiations, such as Parkinson’s disease from other neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetabolomeNervous System DiseasesMagnetic Resonance SpectroscopyHumansMaleFemaleMiddle AgedAgedAdultBiomarkers

Stichwörter der Autor:innen

BiomarkerCerebral IschemiaCerebrospinal FluidMetabolomeMetabolomicsMultiple SclerosisNMR spectroscopyNeurodegenerative diseasesNeurologyParkinson’s DiseaseSerum

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Charitéplatz 1, 10117, Berlin, Germany. carolin.otto@charite.de.
  • Berlin Institute of Health at Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.
  • Lifespin GmbH, Am BioPark 13, 93050, Regensburg, Germany.

Förderung

  • Charité - Universitätsmedizin Berlin

Zitieren

APA

Otto, C., Kalantzis, R., Kübler-Weller, D., Kühn, A. A., Böld, T., Regler, A., Strathmeyer, S., Wittmann, J., Ruprecht, K., & Heelemann, S. (2024). Comprehensive analysis of the cerebrospinal fluid and serum metabolome in neurological diseases. Journal of Neuroinflammation, 21(1). https://doi.org/10.1186/s12974-024-03218-0

Vancouver

Otto C, Kalantzis R, Kübler-Weller D, Kühn AA, Böld T, Regler A, et al. Comprehensive analysis of the cerebrospinal fluid and serum metabolome in neurological diseases. Journal of Neuroinflammation. 2024;21(1). doi:10.1186/s12974-024-03218-0

BibTeX
@article{Otto2024,
  author = {Otto, Carolin and Kalantzis, Rea and Kübler-Weller, Dorothee and Kühn, Andrea A and Böld, Tina and Regler, Armin and Strathmeyer, Selina and Wittmann, Johannes and Ruprecht, Klemens and Heelemann, Steffen},
  title = {Comprehensive analysis of the cerebrospinal fluid and serum metabolome in neurological diseases},
  journal = {Journal of Neuroinflammation},
  year = {2024},
  volume = {21},
  number = {1},
  doi = {10.1186/s12974-024-03218-0}
}
Kostenlos starten →